Disclaimer

You are now leaving www.esmya.com. Links to other websites are provided as a resource to our visitors.

Gedeon Richter accepts no responsibility for the content of other websites.

Esmya® Posology and Dosing

Esmya® mg oral tablet, taken once-daily for courses of up to 3 months

Esmya® Posology & Dosing

The first medical treatment for the long-term management* of uterine fibroids (European Union)

  • Treatment (5 mg oral tablet, taken once-daily) for courses of up to 3 months1
  • Treatments should only be initiated when menstruation has occurred:
    • The first treatment course should start during the first week of menstruation.
    • Re-treatment courses should start at the earliest during the first week of the second menstruation following the previous treatment course completion1.

* Esmya® is indicated in the EU for intermittent and pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age1.

Graphic_21_mois_02_b

 

References

  • 125 Reference 1 - Esmya® SmPC. May 2015.
7fc16655c1
/wp-admin/options-general.php?page=emc2-popup-disclaimer%2Femc2pdc-admin.php
65dc6cecd1
2090
1
Accept
Decline
http://fibroidsconnect.com/
1

For Healthcare Professionals only

This information contained in this website was specifically created for healthcare professionals. Please tick here to confirm that you are a licensed healthcare professional.
Registration conditions of ESMYA® could differ in each country, please refer to your local regulations for more information.

Accept Decline